Select language:

Sputnik V vaccine recognized as safe in India

 / Главная / Russkiy Mir Foundation / News / Sputnik V vaccine recognized as safe in India

Sputnik V vaccine recognized as safe in India


12.01.2021

Photo credit: mos.ru / Y. Ivanko

The Russian Sputnik V vaccine has been recognized as meeting Indian safety standards, TASS reports.

This is the conclusion reached by the Independent Security and Data Oversight Board. After the completion of the 2nd stage of drug research, the board got acquainted with the results of clinical trials and made a recommendation to continue the trial without changes. The board noted that the trials have once again demonstrated that the drug has a high degree of safety.

The research was carried out by the pharmaceutical company Dr. Reddy's Laboratories. Now the third stage will begin, which will be much wider. More than 30,000 volunteers will take part it.

The production of the Russian Sputnik V vaccine should begin in India. The Russian Direct Investment Fund (RDIF) and the Indian pharmaceutical manufacturer Hetero have agreed on this. It is planned that at least one hundred million doses of the drug will be produced every year.

Russkiy Mir

News by subject

Publications

Dostoevsky is online, Tolstoy shared a life hack from country life, and Chekhov posted something funny... Many Russian classic authors have pages in social media, including English-language ones, and they have millions of subscribers. People from all over the world want their news feed to feature posts about new translations of Dostoevsky or a memorable date associated with Leo Tolstoy’s life, not just sales ads and pictures with cute kittens.
Argentina has received, possibly, the most important gift before Catholic Christmas – Sputnik V vaccine from Russia. 300,000 doses have arrived by the airplane that spent almost 24 hours in flight. The Russian vaccine promoter, the Russian Center at the Buenos Aires University has played important role in this action.